← Back to Search

Electrosurgical Generator

Conventional Electrosurgical Coagulation (CEC) Systems for Mastectomy (CHEST Trial)

N/A

Waitlist Available

Led By Stacey A Carter, MD

Research Sponsored by SurgiQuest, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up two months from procedure

Awards & highlights

CHEST Trial Summary

This trial will compare the Helixar Electrosurgical Generator to Conventional Electrosurgical Coagulation for cutting and/or coagulating tissue during mastectomy procedures.

Eligible Conditions

Mastectomy

CHEST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ two months from procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~two months from procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and two months from procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The time measured from post-mastectomy to hemostasis for each operated breast.

Secondary outcome measures

drain output

Other outcome measures

infection rate

CHEST Trial Design

2Treatment groups

Active Control

Group I: Conventional Electrosurgical Coagulation (CEC) SystemsActive Control1 Intervention

Standard Bovie electrosugical device without argon gas

Group II: HelixAR Electrosurgical Generator (HEG)Active Control1 Intervention

Argon gas and high frequency electrical current ablation device

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

SurgiQuest, Inc.Lead Sponsor

5 Previous Clinical Trials

590 Total Patients Enrolled

Stacey A Carter, MDPrincipal InvestigatorBaylor St. Luke's Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people have qualified for this research endeavor?

"Affirmative. According to clinicaltrials.gov, this experiment is currently accepting applications from participants which was initially released on May 26th 2021 and has been revised as of July 8th 2021. The research necessitates 82 volunteers located at a single site."

Answered by AI

Could I become a participant in this experiment?

"This trial is looking for 82 people aged 18 to 80 who have lymphedema and are suitable candidates for a unilateral or bilateral mastectomy with reconstruction. Those enrolled and consenting will undergo the procedure if deemed medically beneficial."

Answered by AI

Is this experiment currently open to new participants?

"Affirmative. The details available on clinicaltrials.gov infer that this research trial is currently searching for participants to take part in the study, which was first made public on May 26th 2021 and has since had its information updated as of July 8th 2021."

Answered by AI

Does this research accept participants under the age of 35?

"This clinical trial has a stated age range of 18-80 years old. Alternatively, there are two separate trials specifically for minors and 76 studies suitable for seniors aged 65 or above."

Answered by AI

Recent research and studies

CancersJournal

Effects of Age on the Detection and Management of Breast Cancer

McGuire, Andrew, James Brown, Carmel Malone, Ray McLaughlin, and Michael Kerin. 2015. “Effects of Age on the Detection and Management of Breast Cancer”. Cancers. MDPI AG. doi:10.3390/cancers7020815.

clinicaltrials.govStudy

ConMed HelixAR™ ElectroSurgical Generator With Argon Beam Coagulation Technology Study

2021. "ConMed HelixAR™ ElectroSurgical Generator With Argon Beam Coagulation Technology Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04165525.